Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

469 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Short-term vitamin D3 supplementation lowers plasma renin activity in patients with stable chronic heart failure: an open-label, blinded end point, randomized prospective trial (VitD-CHF trial).
Schroten NF, Ruifrok WP, Kleijn L, Dokter MM, Silljé HH, Lambers Heerspink HJ, Bakker SJ, Kema IP, van Gilst WH, van Veldhuisen DJ, Hillege HL, de Boer RA. Schroten NF, et al. Among authors: hillege hl. Am Heart J. 2013 Aug;166(2):357-364.e2. doi: 10.1016/j.ahj.2013.05.009. Epub 2013 Jun 24. Am Heart J. 2013. PMID: 23895820 Clinical Trial.
Comparison between New York Heart Association classification and peak oxygen consumption in the assessment of functional status and prognosis in patients with mild to moderate chronic congestive heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy.
van den Broek SA, van Veldhuisen DJ, de Graeff PA, Landsman ML, Hillege H, Lie KI. van den Broek SA, et al. Am J Cardiol. 1992 Aug 1;70(3):359-63. doi: 10.1016/0002-9149(92)90619-a. Am J Cardiol. 1992. PMID: 1632403
Effects of spirapril and captopril on regional blood flow in chronic congestive heart failure: a comparison between a short- and a long-acting angiotensin-converting enzyme inhibitor.
van den Broek SA, de Graeff PA, Smit AJ, Girbes AR, Journée, van Gilst WH, Hillege H, van Veldhuisen DJ, Wesseling H, Lie KI. van den Broek SA, et al. J Cardiovasc Pharmacol. 1995 Jan;25(1):105-12. doi: 10.1097/00005344-199501000-00017. J Cardiovasc Pharmacol. 1995. PMID: 7723338 Clinical Trial.
Oral anticoagulation in the prevention of one-year vein graft occlusion after aortocoronary bypass surgery: optimal therapeutic range and practical limitations. CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands.
van der Meer J, Hillege HL, Dunselman PH, Mulder BJ, Michels HR, Buser PT, van Gilst WH, Lie KI. van der Meer J, et al. Among authors: hillege hl. Thromb Haemost. 1994 Nov;72(5):676-81. Thromb Haemost. 1994. PMID: 7900073
Effects of low dose aspirin (50 mg/day), low dose aspirin plus dipyridamole, and oral anticoagulant agents after internal mammary artery bypass grafting: patency and clinical outcome at 1 year. CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands. Prevention of Coronary Artery Bypass Graft Occlusion by Aspirin, Dipyridamole and Acenocoumarol/Phenprocoumon Study.
van der Meer J, Brutel de la Rivière A, van Gilst WH, Hillege HL, Pfisterer M, Kootstra GJ, Dunselman PH, Mulder BJ, Lie KI. van der Meer J, et al. Among authors: hillege hl. J Am Coll Cardiol. 1994 Nov 1;24(5):1181-8. doi: 10.1016/0735-1097(94)90096-5. J Am Coll Cardiol. 1994. PMID: 7930237 Free article. Clinical Trial.
A comparison of internal mammary artery and saphenous vein grafts after coronary artery bypass surgery. No difference in 1-year occlusion rates and clinical outcome. CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands.
van der Meer J, Hillege HL, van Gilst WH, Brutel de la Rivière A, Dunselman PH, Fidler V, Kootstra GJ, Mulder BJ, Pfisterer M, Lie KI. van der Meer J, et al. Among authors: hillege hl. Circulation. 1994 Nov;90(5):2367-74. doi: 10.1161/01.cir.90.5.2367. Circulation. 1994. PMID: 7955195 Clinical Trial.
469 results